glenzocimab (ACT 017) - Acticor Biotech
https://apps.congrex.com/esoc2024/en-GB/pag/presentation/360223
 
Andrea Comenducci1; Adeline Meilhoc1; Yannick Plétan1; Sophie Binay1; Gilles Avenard1; Alistair Perry2; Olivier Joly2; George Harston2,3; Davide Carone2,3,4
 
Apr 27, 2024
 
Prev Next